Advances in understanding and treating liver diseases during pregnancy: A review

Table 2 Representative laboratory data of intrahepatic cholestasis of pregnancy

Hematology		Biochemistry
WBC	10080/μL	TP	6.8 g/dL	Bile acid	89.6 μmol/L
RBC	410 × 104 /μL	Alb	3.7 g/dL	U acid	0.9 μmol/L
Hb	13.3 g/dL	BUN	8 mg/dL	C acid	21.7 μmol/L
Ht	39.8%	Cre	0.36 mg/dL	C/BA	0.24
PLT	25.5 × 104/μL	T-Bil	6.3 mg/dL	HbA1c	4.2%
		D-Bil	4.0 mg/dL	Serum marker
Coagulation		AST	264 IU/L	HBs Ag	(-)
PT%	121%	ALT	545 IU/L	Anti-HBs	(-)
		ALP	310 IU/L	Anti-HBc	(-)
		LDH	241 IU/L	Anti-HCV	(-)
		γ-GTP	14 IU/L	AFP	36 ng/mL
		ChE	137 IU/L	AFP-L3	32.8%
		TG	197 mg/dL	PIVKAII	44 mAU/mL
		TC	191 mg/dL	ANA	(-)
		IgG	908 mg/dL	AMA	(-)
		CRP	0.05 mg/dL

TG: Triglyceride; TC: Total cholesterol; IgG: Immunoglobulin G; U acid: Ursodeoxycholic acid; C acid: Chenodeoxycholic acid; AFP: Alpha fetal protein; PIVKA: Protein induced by Vitamin K absence or antagonists-II; ANA: Anti-nuclear antibody; AMA: Anti-mitochondrial antibody. Reconstructed from ref [19] with permission.